Micrus Endovascular (Buffett Intrinsic Value Analysis)
 Improve your investment analysis with by seeing the Micrus Endovascular's Discounted Cash Flow analysis, Micrus Endovascular's Comparable Multiple analysis, and Micrus Endovascular's Weighted Average Cost of Capital (WACC) Analysis. Helpful Information for Micrus Endovascular's AnalysisHow does this work? The Warren Buffett Intrinsic Value Analysis, developed exclusively by WikiWealth, tries to mimic the value investing approach used by Warren Buffett. Value Investing Importance? This method is unique and experimental, but extensive testing on over 3,200 companies confirms the results to be surprisingly accurate and consistent with more advanced approaches. |
Notes on the Buffett AnalysisWarren Buffett's formula was never published; however, from our research and Warren Buffett's hints over the years, this formula seems to be the most likely candidate. WikiWealth actually uses this formula in all our research reports in conjunction with Buffett's qualitative assessments of value. The numerator for this equation is found on the DCF valuation for Micrus Endovascular. It's NOPAT + Depreciation - CapEx - Net Working Capital Change. The risk free rate is the US treasury rate, a standard risk free measurement. The Warren Buffett intrinsic valuation is a simplified version of Micrus Endovascular's discounted cash flow analysis. Click on the link to see the analysis. See Micrus Endovascular's equity valuation for the complete analysis. |
